Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
06/2006
06/21/2006EP1670775A1 Piperazine subtituted compounds used as calcium channel blockers
06/21/2006EP1670744A1 4-((phenoxyalkyl)thio)-phenoxyacetic aci ds and analogs
06/21/2006EP1049662B1 Inhibitors of alpha4 mediated cell adhesion
06/21/2006EP0957080B1 Novel ethylamine derivatives
06/21/2006CN1791572A Novel compounds
06/21/2006CN1789259A Process for synthesizing vinylene carbonate
06/21/2006CN1789258A Addition reaction method for preparing cyclic carbonate from epoxide and carbon dioxide
06/21/2006CN1260231C 2,2-dimethylene dioxy group 1,3-propylene glycol carbonate, preparation method and application thereof
06/21/2006CN1260222C Antagonists of mcp-1 function and methods of use thereof
06/21/2006CN1260221C Method for preparing platinum(II) metal complex eptaplatin
06/20/2006US7064128 Preferentially substituted calcium channel blockers
06/15/2006WO2006062093A1 Novel anthranilic acid derivative or salt thereof
06/15/2006WO2006044379A3 Novel curcumin analogues and uses thereof
06/15/2006WO2005089815A3 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
06/15/2006WO2005085188A3 Compounds and methods for anti-tumor therapy
06/15/2006WO2005058862B1 Method for producing glycerol carbonate methacrylate
06/15/2006US20060128976 Process for producing trifluoromethyl-substituted 2-alkoxyacetophenone derivatives
06/15/2006US20060128801 Organic compounds
06/15/2006US20060128790 5,7,8-Trimethyl-3,4-dihydrospiro[chromene-2,1'-cyclobutan]-6-ol; also analogous thiochromenes; antiapoptosis; anticarcinogenic agents; antihypoxic agents; anoxia; antiinflamatory agents; central nervous system disorders; autoimmune diseases; neurodegenerative disorders
06/15/2006CA2588633A1 Novel anthranilic acid derivative or salt thereof
06/14/2006EP1669384A2 Mixtures of binders which contain bicycloorthoester and/or polyorthoester groups
06/14/2006EP1669353A1 Process for preparing alpha, beta - unsaturated ester
06/14/2006EP1668985A2 Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
06/14/2006EP1668007A1 Dioxolane derivatives as cell adhesion inhibitors
06/14/2006EP1102742B1 Compounds and compositions for delivering active agents
06/14/2006CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient
06/14/2006CN1787985A Process of removing organic halogen-containing compounds
06/14/2006CN1785994A Method of preparing heliotropin by using p-methyl phenol as raw material
06/14/2006CN1785960A Preparation method of alpha-alkyl-isoserine and byproduct
06/14/2006CN1259307C Acylated indanyl amines and their use as pharmaceuticals
06/13/2006US7060847 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs
06/13/2006CA2272539C Process for the stereoselective production of nitro-enamine compounds
06/13/2006CA2260777C Pentafluorobenzenesulfonamides and analogs
06/08/2006WO2006058893A2 Use of diacetyl trimer as an aromatic and flavouring substance
06/08/2006WO2006058700A1 Acetamide compounds as fungicides
06/08/2006US20060122408 Photogenerated reagents
06/08/2006US20060122406 Hydroxylation process for aromatic compounds containing a dioxa-heterocyclic system
06/08/2006US20060122404 Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of-alpha-perfluoroalkylamines
06/07/2006EP1664002A1 Organic compounds
06/07/2006EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
06/07/2006EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same
06/07/2006CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators
06/06/2006US7057038 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
06/06/2006US7056902 4-dedimethylamino tetracycline compounds
06/06/2006US7056347 Intense, stable blue color shades can be obtained in addition to natural and purple or violet shades.
06/06/2006CA2215066C Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
06/01/2006WO2006058088A2 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
06/01/2006WO2006056087A1 Carboxamides and their use
06/01/2006WO2005040149A8 Process for the preparation of glyceraldehyde acetonide
06/01/2006WO2005034940A8 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
06/01/2006US20060116534 Process for manufacture of an allyl ether
06/01/2006CA2588607A1 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
05/2006
05/31/2006EP1661885A1 Optically active alpha-aminooxyketone derivatives and process for production thereof
05/31/2006EP1661882A1 Compound having anti-hcv activity and process for producing the same
05/31/2006EP1661564A1 Heterocyclic compounds and their pharmaceutical use
05/31/2006EP1660859A2 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
05/31/2006EP1660471A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors
05/31/2006EP1660427A1 Substituted arylalkanoic acid derivative and use thereof
05/31/2006EP1659881A2 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/31/2006EP1448181B1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
05/31/2006EP1420644B1 Substituted propargylamines
05/31/2006EP1296931B1 Polyamine analogues as cytotoxic agents
05/31/2006EP1251822A4 Novel coupler for use in oxidative hair dyeing
05/31/2006EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
05/31/2006CN1780828A Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives
05/31/2006CN1780811A Diphenylethylene compounds and uses thereof
05/31/2006CN1257886C Dehydroamino acids compounds
05/30/2006US7053248 Process for producing trifluoromethyl- substituted 2- alkoxyacetophenone derivatives
05/30/2006US7053234 Antibacterial agents
05/30/2006US7053225 Such as 2-(t-butyldimethylsilyloxymethyl)-3,4-((dimethylmethylene)-dioxy)-5-hydroxy -tricyclo(5.2.1.02,6) deca-3,8-diene; for Diels-Alder reaction; antitumor agents
05/30/2006US7053224 Intermediates and improved processes for the preparation of neplanocin A
05/30/2006US7053109 Aminediols for the treatment of Alzheimer's disease
05/30/2006US7053082 Neuroprotectants for treating epilepsy, stroke, Parkinson's disease, multiple sclerosis or amyotropic lateral sclerosis; 5-(3-methyl-4-amino or nitro-phenyl)-1,3-dioxolo[4,5-h][2,3]benzodiazepine; AMPA/cainate antagonistic effect; chemical intermediates
05/30/2006CA2187969C A template for solution phase synthesis of combinatorial libraries
05/30/2006CA2161246C Fullerene derivatives, methods of preparing them and their use
05/26/2006WO2006055725A2 Substituted amino acids as protein tyrosine phosphatase inhibitors
05/26/2006WO2006053748A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases
05/26/2006CA2588776A1 Substituted amino carboxylic acids
05/26/2006CA2587511A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases
05/25/2006US20060111406 Amide linker peroxisome proliferator activated receptor modulators
05/24/2006EP1658278A2 Method for producing fluorinated 1,3-dioxolane compounds, fluorinated 1,3-dioxolane compounds, fluorinated polymers of the fluorinated 1,3-dioxolane compounds, and optical or electrical materials using the polymers
05/24/2006EP1658263A1 Novel aminobenzophenone compounds
05/24/2006EP1478613B1 Substituted 10-aryl-11h-benzo¬b|fluorenes for selective effects on estrogen receptors
05/24/2006CN1777577A Antibacterial agents
05/24/2006CN1777572A Process for preparing alkoxy- and aryloxy-phenols
05/24/2006CN1777568A Process for manufacture of an allyl ether
05/24/2006CN1257153C Novel propargylether derivatives
05/23/2006US7049448 Reacting cyclohexanedione with diol in halogenated solvent in presence of acid catalyst
05/23/2006CA2173747C Calcium receptor-active arylalkyl amines
05/18/2006WO2006050842A1 Dibenzosuberone derivatives
05/18/2006US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type
05/18/2006US20060106224 Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles from cyclohexanes and cyclohexanones as intermediates
05/18/2006US20060106053 Therapy of adenocarcinoma of the colon and rectum
05/18/2006US20060105002 Preparation of lactic acid derivatives and their use
05/18/2006CA2586068A1 Dibenzosuberone derivatives
05/17/2006CN1772747A Synthesis of 1, 4-dioxo spiro [4, 5] decane-8-one
05/17/2006CN1772746A Synthesis of phenylacetaldehyde phenylglycol acetal as one kind of flower fragrance type perfume
05/17/2006CN1256335C Ketal intermediate obtained from preparation of trion-bis(oxime ether) derivatives
05/16/2006US7045641 Process for preparing polyenedialdehyde monoacetals
05/16/2006US7045518 Compounds for treatment of AIDS with enzyme inhibitors
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 183